SGC-GAK-1
CAY-33229-50 50 mg
Data Sheet: 
SDS:
SDS:
CAS
2226517-76-4
Formulation
A crystalline solid
Purity
≥98%
MW
389,24326
Shipment
-20
Long Term Storage
-20
Shelf Life
1460
Description
A GAK inhibitor (Ki = 3.1 nM); >50-fold selective for GAK over a panel of 400 kinases at 1 µM but does bind to RIPK2 (IC50 = 360 nM in a BRET engagement assay); reduces the viability of LNCaP and 22Rv1 prostate cancer cells (IC50s = 0.65 and 0.17 µM, respectively); inhibits dengue virus infection in Huh7 cells (EC50 = 0.08 µM)
ESCLUSIVAMENTE PER USO DI RICERCA (RUO) e non per uso terapeutico o diagnostico su uomini o animali. Il prodotto NON è un Dispositivo Medico o un Diagnostico in Vitro.
PRODUCT FOR RESEARCH USE ONLY (RUO) and not for therapeutic or diagnostic use on humans or animals. The product is NOT a Medical Device or an In-Vitro Diagnostic (IVD).
